Navigation Links
Hepatitis C Carries Another Risk-Cancer Of The Immune System

According to a report published in the Journal of the American Medical Association, research points to a new risk of Hepatitis C- the chance of contracting lymphoma.

The cancer of the immune system-lymphoma or non-Hodgkins lymphoma is found to be 30 percent times higher in patients with hepatitis C, and for another cancer Waldenstroms macroglobulinemia, the risk of a hepatitis C patient contracting it is 300 times higher.

More than 4 million Americans have hepatitis C, and about 26,000 new cases are diagnosed each year, according to the U.S. Centers for Disease Control and Prevention.

Lymphomas are cancers that originate in the lymphatic system, a part of the body's immune system. The two most common forms of lymphoma are Hodgkin's and non-Hodgkin's lymphoma. About 8,000 Americans develop Hodgkin's lymphoma and more than 56,000 develop non-Hodgkin's lymphoma each year, according to the Leukemia and Lymphoma Society.

Non-Hodgkin's lymphoma is cancer that originates in the lymphoid tissue that makes up the lymph nodes, spleen and other organs of the immune system, with tumors developing from white blood cells. It is more common in men than women.

Says study author Dr. Thomas Giordano, assistant professor of medicine at Baylor College of Medicine in Houston: "If I had hepatitis C, this would be one more piece of evidence that might make me consider treatment, though hepatitis C treatment can be difficult and is often unsuccessful. On the other hand, the risk of these cancers is so small; I wouldn't panic if wasn't getting treatment either. The overall risk is low.

According to Giordano ,chronic stimulation of the immune system caused by hepatitis C might be contributing to the development of certain lymphomas.

The study subjects recruited were 150,000 veterans from the Veteran Administration (Vietnam War). The scientists marked those with a diagnosis of hepatitis C, and then they matched by ag e and sex four healthy veterans for each person infected with hepatitis C. Nearly all of the veterans included in the study were male, and the average age was 52.

The researchers found that just fewer than 1,400 people included in the study developed non-Hodgkin's lymphoma and 165 developed Waldenstrom's lymphoma.

The risk of non-Hodgkin's lymphoma was 28 percent higher for those with hepatitis C, and the risk of Waldenstrom's was 276 percent higher.

While women only comprised 3 percent of the study population, Giordano believes the results would probably apply to women as well.

According to Marshall Lichtman, executive vice president for research and medical progress for the Leukemia & Lymphoma Society, the study could help scientists better understand the connection between infection and cancer. Several infectious agents the Epstein-Barr virus, HIV and bacteria called Helicobacter pylori are all associated with lymphoma.

Experts say that these organisms could cause cancer this way: Immune cells flock to the infection site, then make lots of copies of themselves to outnumber the viruses or bacteria that they want to kill. Most of the copies are normal, but a few have genetic mistakes, or mutations, that lead to cancer.

Worldwide, about one in five cancers are caused by infection. Doctors can prevent some of these cancers with vaccines, such as the hepatitis B vaccine, which can reduce the risk of liver cancer, or the new vaccine against human papillomavirus, which protects against most cervical cancers.

Giordano says that as there's no standard screening tool for lymphoma, there aren't any immediate practical implications from the findings. He said the findings may help researchers, and they may alert physicians to think of the possibility of lymphoma in their hepatitis C patients.


'"/>




Related medicine news :

1. Vitamin B for Hepatitis
2. Hepatitis G May Boost HIV Survival
3. Cure for Hepatitis B
4. Hepatitis E virus made impotent
5. Sharing injection equipment spreads Hepatitis C
6. Lymphomas Link to Hepatitis C
7. Hepatitis shots is promising
8. Need for Hepatitis Booster Questioned
9. Good News for HIV Patients Also Suffering From Hepatitis C Virus
10. The Link Between Hepatitis B Vaccine And Multiple Sclerosis Questioned
11. The Effectiveness Of Hepatitis B Vaccine Questioned
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/8/2016)... ... 2016 , ... STATEN ISLAND, N.Y., Nov. 24, 2016 — ... highest standards of trauma, maternity, cancer and chronic obstructive pulmonary disease (COPD) services ... Daniel Messina. , Among the recognitions, the American College of Surgeons' (ACS) named ...
(Date:12/8/2016)... ... ... California Senate Bill (SB) 863, signed into law in 2012, may have ... according to CompScope™ Medical Benchmarks for California, 17th Edition , a study by ... payments per claim in California decreased 4 percent in 2013 and then 3 percent ...
(Date:12/8/2016)... ... December 08, 2016 , ... Healthcare is in flux. The ... for the mass media launching of story movements to highlight what's most unfair ... unfortunate experiences; such a movement can generate the network power to improve healthcare ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... services from offices headquartered in Little Rock, has initiated a charity drive to ... the National Foundation to End Senior Hunger, Arkansas ranks first in senior hunger ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... services from offices headquartered in Jefferson County, is announcing the launch of a ... Birmingham. , The number of homeless women and children in Birmingham has grown ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... Research and Markets has announced the addition of the ... ... The global chromatography market to grow at a CAGR of 5.42% during ... prepared based on an in-depth market analysis with inputs from industry experts. ... coming years. The report also includes a discussion of the key vendors ...
(Date:12/8/2016)... 2016 According to a ... Product (Actual Sugars, Sugar Alcohols, Artificial Sweeteners), Type ... Agents), Formulation (Oral, Topical, Parenteral) - Global Forecast ... witnessed healthy growth during the last decade, and ... 4.3% between 2016 and 2021 to reach USD ...
(Date:12/8/2016)... SAN FRANCISCO, Calif. , Dec. 8, 2016 ... nuclease technology to develop novel antiviral therapeutics, today ... M.D., as chief executive officer and a member ... is an incredibly experienced executive with a deep ... said Stephen Quake, D.Phil., founder of Agenovir, co-president ...
Breaking Medicine Technology: